Literature DB >> 24548632

Dual blockade of endothelin action exacerbates up-regulated VEGF angiogenic signaling in the heart of lipopolysaccharide-induced endotoxemic rat model.

Masami Oki1, Subrina Jesmin1, Md Majedul Islam1, Chishimba Nathan Mowa2, Tanzila Khatun1, Nobutake Shimojo1, Hideaki Sakuramoto1, Junko Kamiyama1, Satoru Kawano1, Takashi Miyauchi3, Taro Mizutani1.   

Abstract

AIMS: Sepsis is a cluster of heterogeneous syndromes associated with progressive endotoxemic developments, ultimately leading to damage of multiple organs, including the heart. However, the pathogenesis of sepsis-induced myocardial dysfunction is still not fully understood. The present study is the first to examine alterations in expression of key angiogenic signaling system mediated by vascular endothelial growth factor (VEGF) in septic heart and the effects of endothelin dual blocker (ETDB) on it. MAIN
METHODS: Normal Wistar rats were either administered with: a) vehicle only (control group), b) lipopolysaccharide only (LPS: 15 mg/kg) and then sacrificed at different time points (1 h, 3 h, 6 h and 10 h), and c) the last group was co-administered with LPS and ETDB (SB-209670, 1 mg/kg body weight) for 6 h and then sacrificed. KEY
FINDINGS: Administration of LPS resulted in increases in levels of: a) serum tumor necrosis factor (TNF)-α, b) serum VEGF and c) serum endothelin (ET)-1 levels accompanied by up-regulation of cardiac VEGF and its downstream angiogenic signaling molecules. While cardiac TNF-α level was unchanged among experimental groups, cardiac ET-1 level was significantly higher in LPS-administered group. SIGNIFICANCE: We conclude that elevation in VEGF angiogenic signaling may be triggered by diminished oxygenation in the myocardium following LPS administration as a consequence of sepsis-induced microvascular dysfunction. Because of this cardiac dysfunction, oxygen supply may be inadequate at microregional level to support the normal heart metabolism and function. ETDB at 6 h further increased the elevated levels of VEGF angiogenic signaling in endotoxemic heart.
Copyright © 2014 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Endothelin receptor antagonist (SB-209670); Endotoxemic heart; Lipopolysaccharide; Vascular endothelial growth factor

Mesh:

Substances:

Year:  2014        PMID: 24548632     DOI: 10.1016/j.lfs.2014.02.008

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  3 in total

1.  Lipopolysaccharides Improve Mesenchymal Stem Cell-Mediated Cardioprotection by MyD88 and stat3 Signaling in a Mouse Model of Cardiac Ischemia/Reperfusion Injury.

Authors:  Xiaona Chu; Bing Xu; Hongyu Gao; Bai-Yan Li; Yunlong Liu; Jill L Reiter; Yue Wang
Journal:  Stem Cells Dev       Date:  2019-04-11       Impact factor: 3.272

2.  Alterations of Thymic Epithelial Cells in Lipopolysaccharide-induced Neonatal Thymus Involution.

Authors:  Yong-Jie Zhou; Hua Peng; Yan Chen; Ya-Lan Liu
Journal:  Chin Med J (Engl)       Date:  2016-01-05       Impact factor: 2.628

3.  Correlation between plasma endothelin-1 levels and severity of septic liver failure quantified by maximal liver function capacity (LiMAx test). A prospective study.

Authors:  Magnus F Kaffarnik; Navid Ahmadi; Johan F Lock; Tilo Wuensch; Johann Pratschke; Martin Stockmann; Maciej Malinowski
Journal:  PLoS One       Date:  2017-05-23       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.